Zepbound australia

After the initial limited release of Zepbound  Australia in Australia, it is speculated that it’s manufacturer Eli Lilly would continue current studies to expand Zepbound’s registered uses as well as ensure they have enough stock to allocate to Australian patients under the expanded registered uses. This is particularly important given other GLP-1 receptor agonists like Zepbound have experienced supply issues due to popularity and complex manufacturing in recent years.

Is zepbound available in australia

Currently, there is no confirmed cost of Zepbound pens in Australia. THE vials are likely to be between $350 to $700 a month depending on your dose. Like other treatments in its medicine family, GLP-1 receptor agonists, it is a high but similar price.

Whilst this can be high in comparison to other treatments that are available, the complex manufacturing and transport processes generally contribute to the higher-end cost.

Eli Lilly’s first application for it’s PBS listing failed after failure to meet its cost-effectiveness test. Further applications to be listed on the Pharmaceutical Benefits Scheme (PBS) as a public health measure are likely. If approved, it will greatly reduce the cost to patients in Australia.

Zepbound vs Wegovy

• Zepbound (tirzepatide) and Wegovy (semaglutide) are two once-weekly injectable medications for chronic weight management. Wegovy is approved for certain adults and adolescents ages 12 and older. it is approved only for adults. Both medications work in similar but slightly different ways.

• It may result in greater weight loss compared with Wegovy. If you need more help managing your weight, it’s possible to switch from Wegovy to it. But Wegovy may be a good option if you have heart disease.

• There are ways to save on Zepbound and Wegovy, which are available as brand-name medications. If you’re eligible, manufacturer copay cards can help make your prescription more affordable.